Avient (NYSE:AVNT) reported Q2 2025 results, with adjusted EPS of $0.80 exceeding estimates and revenue reaching $866.5 million, up 2% YoY. The company saw a decline in operating income for this segment. Avient operates in specialty materials, focusing on high-value applications in healthcare, defense, and sustainable materials. Despite weak demand in certain markets, Avient showed steady growth in high-margin segments. The company used cash flow to pay down debt and remains on track for debt reduction goals. Looking ahead, Avient forecasts adjusted EPS of $0.70 for Q3 and narrowed full-year guidance to $2.77-$2.87 for fiscal 2025, with a focus on margin expansion and cost control.

Read more at Nasdaq: Earnings Summary on Avient | Nasdaq